Schedule 13G ownership disclosure

ZYVERSA THERAPEUTICS INC

Security class unavailable · CUSIP: 98987D102

Event date: 2023-01-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
874,698
Percent of class
9.6300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001062993-23-000904
Form type
SC 13G
Filer
Titcomb Shawn
CIK
CIK 1786406
Filed
Jan 13, 2023
Reporting period
Jan 13, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub